Glucuronic acid, monosodium salt

Suppliers

Names

[ CAS No. ]:
7182-77-6

[ Name ]:
Glucuronic acid, monosodium salt

[Synonym ]:
Monosodium glucuronate
glucuronicacid,monosodiumsalt
Sodium Glucurononate
URSODEOXYCHOLICACID
Sodium Glucoronic

Chemical & Physical Properties

[ Boiling Point ]:
553.4ºC at 760 mmHg

[ Molecular Formula ]:
C9H6FN

[ Molecular Weight ]:
147.14900

[ Flash Point ]:
302.6ºC

[ Exact Mass ]:
147.04800

[ PSA ]:
23.79000

[ LogP ]:
2.36248

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
LZ8950000
CHEMICAL NAME :
Glucuronic acid, monosodium salt
CAS REGISTRY NUMBER :
7182-77-6
LAST UPDATED :
199103
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C6-H9-O7.Na
MOLECULAR WEIGHT :
216.14
WISWESSER LINE NOTATION :
T6OTJ BVO CQ DQ EQ FQ &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>20 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,225,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
7534 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,225,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,225,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
5890 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,225,1982

Related Compounds

  • phosphoenolpyruvic acid monosodium salt
  • Selenic acid, monosodium salt
  • D-Glucuronic acid,1-[(4-pyridinylcarbonyl)hydrazone], monosodium salt (9CI)
  • 1-O-METHYL-β-D-GLUCURONIC ACID, SODIUM SALT
  • 8-hydroxyquinoline-beta-d-glucuronic acid, sodium salt
  • 4-bromophthalic acid monosodium salt
  • 2,2,2-Trifluoro-1-{5-oxa-8-azaspiro[3.5]nonan-8-yl}ethan-1-one
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide